Should I refer this 20‑year‑old woman with thalassemia and persistent glucosuria, a normal fasting glucose, and a low HbA1c to endocrinology for further evaluation?

Yes, refer this patient to endocrinology for evaluation of possible occult diabetes and renal glucosuria.

In a 20-year-old woman with thalassemia presenting with persistent glucosuria, normal fasting glucose, and low HbA1c, endocrinology referral is warranted because thalassemia renders HbA1c unreliable for diabetes screening, and she requires alternative glycemic assessment methods to rule out occult diabetes.

Why HbA1c Cannot Be Trusted in Thalassemia

Thalassemia fundamentally distorts HbA1c measurements through multiple mechanisms:

• Increased red blood cell turnover shortens erythrocyte lifespan, preventing adequate glycation time 1, 2
• Altered hemoglobin composition interferes with laboratory assays, particularly HPLC methods 3
• HbA1c can be falsely low despite significant hyperglycemia, masking diabetes for years 1, 2

The 2025 ADA guidelines acknowledge that diabetes diagnosis requires plasma glucose or A1C criteria 4, but they do not account for hemoglobinopathy interference. Multiple recent case reports (2025-2026) demonstrate patients with thalassemia presenting with diabetic ketoacidosis or severe hyperglycemia despite HbA1c values as low as 1.6-3.4% 1, 2, 3, 5.

What Endocrinology Should Evaluate

The endocrinologist needs to perform alternative glycemic assessments that are not affected by red blood cell turnover:

1. Oral glucose tolerance test (OGTT) - the gold standard when HbA1c is unreliable 4, 3
2. Fructosamine or glycated albumin - reflects 2-3 week glycemic control independent of RBC lifespan 2, 3, 5
3. Continuous glucose monitoring - provides real-time glucose patterns 2, 6

The Glucosuria Red Flag

Persistent glucosuria with normal fasting glucose creates two concerning possibilities:

• Occult diabetes with postprandial hyperglycemia that fasting glucose misses (OGTT would detect this) 4
• Renal glucosuria (benign lowered renal threshold for glucose reabsorption)

You cannot distinguish between these without formal testing. Given that thalassemia patients have increased diabetes risk from iron overload and chronic transfusions 7, assuming benign renal glucosuria is dangerous.

Common Pitfall to Avoid

Do not reassure this patient based on the low HbA1c alone. Research from 2016 shows that even mild forms of alpha thalassemia (with 2-3 functional genes) may not significantly affect HbA1c 8, but more severe forms absolutely do. Without knowing her specific thalassemia genotype and severity, you cannot determine if her HbA1c is reliable. The presence of glucosuria suggests it is not.

The Broader Thalassemia-Endocrine Connection

Thalassemia patients, particularly those requiring transfusions, face multiple endocrine complications from iron overload affecting the pancreas, thyroid, parathyroid, and gonads 7. A 2025 framework emphasizes that 50.5% of thalassemia patients have growth issues and 45.8% have hypogonadism, with impaired glucose metabolism affecting 5% 7. This patient needs comprehensive endocrine screening beyond just diabetes assessment.

The endocrinologist can establish appropriate long-term monitoring using fructosamine or glycated albumin rather than HbA1c 2, 3, 5, ensuring she doesn't develop undiagnosed diabetes over time.